Remora Capital SA is an independent Biotech Venture Company based in Lausanne with core focus on immunotherapy. | As immunologists and serial entrepreneurs, we contributed to the biopharmaceutical revolution, driven by immunology, that brought vaccines against pandemics, monoclonal antibodies as the most successful class of drug, immune treatments as breakthrough cures of cancer and autoimmune diseases, and new hopes to fight degenerative diseases. | We created Remora Capital to leverage our expertise in these fields and, thanks to our supporting shareholders, nurture and develop more life-changing advanced bio-therapeutics. | With our growing team and network of business-oriented scientists, patent experts, drug developers and finance professionals, we create, finance, and manage a portfolio of companies from discovery to clinical proof-of-concept. We aim at maximizing their odds of success and their strategic value for pharma partners while keeping capital efficient. | We offer frequent investment opportunities in our holding Remora Capital and in our participations to Investors keen to gain exposure to these high growth sector under the leadership of seasoned entrepreneurs.

5

-

-

-

-

2009

Fund Management Company

Early-Stage, Seed Capital, Start-up Capital

Biotechnology

France, Switzerland

Majority Equity, Minority Equity

-

-

-

-

-